<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.3" -->
<rss version="2.0">
	<channel>
		<title>Two FDA Decisions Pending for Santarus (NASDAQ:SNTS)</title>
		<description>Comments for Two FDA Decisions Pending for Santarus (NASDAQ:SNTS) at http://www.biomedreports.com , comment 1 to 1 out of 1 comments</description>
		<link>http://www.biomedreports.com</link>
		<lastBuildDate>Wed, 08 Feb 2012 18:00:45 +0100</lastBuildDate>
        <generator>FeedCreator 1.7.3</generator>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/2009112418841/santarus-snts-has-two-upcoming-fda-approval-dates.html#comment-1422</link>
			<description>Generic for Omerprazole magnesium came out few years ago for OTC use. The brand name called prilosec was made by AstraZeneca. Since its licence expired, it opens flood gate for other companies to make generic form of prilosec. They aren't the only company or the 1st to make generic form of prilosec. Nothing to be surpised about.  - jman</description>
			<pubDate>Fri, 20 Nov 2009 01:34:50 +0100</pubDate>
		</item>
	</channel>
</rss>

